Profounda is a product-oriented, privately backed pharmaceutical company that aims to license or develop high quality specialty niche pharmaceutical products in both the branded and generic pharmaceutical markets. Our objectives are to bring high quality, innovative options to patients being treated for various conditions, and to improve the lives of those that take our medication. Profounda's commercial products include Impavido® for Leishmaniasis and Rhinase® Nasal Gel and Rhinase® Nasal Mist to help patients with nasal dryness.